Protalix Biotherapeutics, Inc. (PLX)

1.99 -0.03 (-1.49%) USD  |  NYAM  |  Jan 14, 10:35
More

Protalix Biotherapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
OraSure Technologies, Inc. Upgrade
PAVmed, Inc. Upgrade
Denali Therapeutics, Inc. --
AIM ImmunoTech, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade